Vytorin - There’s none so blind….

By admin | February 1, 2008

Submitted by PharmaGossip Blog

As those who choose not to see!

If the treatment effect was nil, would the blinded data from ENHANCE have foretold the results of the surrogate-end-point trial?

Some imaging experts say yes!

Visit 1800blogger to see all of our industry leading blogs.

Rating 3.00 out of 5
[?]

We don't know every stock and we want to know your thoughts. Register on Biotech Stocks Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.

Comments